期刊文献+

食管癌三维适形放疗临床靶体积对预后影响的Meta分析 被引量:6

Meta-Analysis of the Effect of Clinical Target Volume for Three Dimensional Conformal Radiotherapy for the Treatment of Esophageal Carcinoma
暂未订购
导出
摘要 目的评估三维适形放疗不同临床靶体积对食管癌的疗效及副作用。方法计算机检索美国医学文献索引(MEDLINE)、中国生物医学文献数据库(CBM)、中国期刊全文数据库(CNKI)、中文科技期刊全文数据库(VIP)。对收集的文章进行评价,剔除不适合本文研究目的或质量要求的文章。对同质的研究,采用RevMan5.1.6软件进行Meta分析。结果共纳入5项随机对照研究,包括405例患者。Meta分析结果显示:试验组与对照组相比,1年生存率优势比1.05,95%可信区间(0.65,1.71),P值为0.83,差异无统计学意义;1年局部控制率优势比0.92,95%可信区间(0.57,1.50),P值为0.75,差异无统计学意义。放射性肺炎优势比1.79,95%可信区间(1.14,2.82),P值为0.01;放射性食管炎优势比1.98,95%可信区间(1.11,3.51),P值为0.02,差异有统计学意义。结论在食管癌的三维适形放疗中,以大照射野为基础试验组与对照组比较,并不能改善患者1年生存率和1年局部控制率,反而增加患者放射性肺炎和放射性食管炎发生率。本研究纳入病例较少,其结果尚需要多中心大样本随机对照试验进一步验证。 Objective To evaluate the clinical efficacy and toxicities of the three-dimensional conformal radiotherapy for esophageal carcinoma by analyzing the different clinical target volume. Methods An electronic search was performered in American medical literature index (MEDLINE), China national knowledge infrastructure(CNKI) digital library, China biomedicine literature database(CBM) and Chinese science and technology periodical database (V1P). The trials were collected and evaluated according to the inclusion and exclusion criteria. The meta-analysis was performed for the results of homogeneous studies by RevMan 5.1.6 software. Results The meta-analysis included 5 trials. A total of 405 patients were included in the analysis. There was no statistically significant difference in 1-year survival rate between the experimental group and the control group with RR 1.05, 95%CI (0.65,1.71), P=0.83; the similar results also were found in 1-year locoregional control rate with RR 0.92, 95%CI (0.57, 1.50), P=0.75; However the radioactive pneumonia, radiation esophagitis for the two groups had statistical significant difference with RR 1.79, 95%CI (1.14,2.82), P=O.O1 and RR 1.98, 95%CI (1.11,3.51), P=0.02, respectively. Conclusion Compared with control group, the experimental group based on large radiation field did not improve 1-year survival rate and 1-year locoregional control rate of patients, but increased higher incidence of radioactive pneumonia and radiation esophagitis in patients. In the radiotherapy of esophageal carcinoma, the results of this study including few cases that needs a larger sample, multi-center randomized controlled trials to be evidenced.
出处 《循证医学》 CSCD 2012年第6期363-368,共6页 The Journal of Evidence-Based Medicine
关键词 食管肿瘤 适形放射治疗 临床靶体积 META分析 esophageal carcinoma 3-dimensional conformal radiotherapy clinical target volume meta-analysis
  • 相关文献

参考文献14

二级参考文献91

共引文献341

同被引文献52

  • 1袁双虎,于金明,于甬华,杨新华,付政,杨国仁,郭洪波,王晓航,周英智,陈少卿.^(18)F-脱氧葡萄糖PET-CT检测食管癌病变长度的临床价值[J].中华放射肿瘤学杂志,2006,15(5):389-392. 被引量:46
  • 2郭洪波,于金明,张百江,杨国仁,付政,张为迪,黄勇,刘聿辉.^(18)F-FDG PET/CT显像对食管癌原发灶长度的测量[J].中华核医学杂志,2007,27(3):185-186. 被引量:6
  • 3Gao XS, Qiao X, Wu F, et al. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gas- troesophageal junction carcinoma. Int J Radiat Oncol Biol Phys, 2007, 67(2) : 389-396.
  • 4Song Y, Liang Y, Zang R, et al. Application of serial section method to determine the radiotherapy target volume for esophageal squamous carcinoma. Cell Biochem Biophys, 2013, 66(2) : 351-356.
  • 5Yentz S, Wang TD. Molecular imaging for guiding oneologic prognosis and therapy in esophageal adenocarcinoma. Hosp Pract (1995), 2011, 39(2): 97-106.
  • 6Yue J, Chen L, Cabrera AR, et al. Measuring tumor cell proliferation with ^18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study. J Nucl Med, 2010, 51 (4): 528- 534.
  • 7Nakai Y, Shinoura S, Ahluwalia A, et al. Molecular imaging of epi- dermal growth factor-receptor and survivin in vivo in porcine esophage- al and gastric mucasae using probe-based confocal laser-induced endo- microscopy: proof of concept. J Physiol Pharmacol, 2012, 63 ( 3 ) : 303 -307.
  • 8Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of local- ly advanced esophageal cancer: long-term follow-up of a prospective randomized trim (RTOG 85-01 ). Radiation Therapy Oncology Group. JAMA, 1999, 281(17) : 1623-1627.
  • 9Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncolagy Group 94-05 ) phase Ⅲ trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol, 2002, 20(5) : 1167-1174.
  • 10Ajani JA, Winter K, Komaki R, et al. Phase Ⅱ randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol, 2008, 26(28) : 4551-4556.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部